CardieX Limited (ASX:CDX)

Australia flag Australia · Delayed Price · Currency is AUD
0.0380
-0.0030 (-7.32%)
Jul 25, 2025, 3:40 PM AEST
-7.32%
Market Cap20.90M
Revenue (ttm)5.72M
Net Income (ttm)-14.55M
Shares Out550.08M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume903,951
Average Volume307,333
Open0.0380
Previous Close0.0410
Day's Range0.0370 - 0.0380
52-Week Range0.0370 - 0.1750
Beta1.11
RSI43.08
Earnings DateAug 29, 2025

About CardieX

CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; an... [Read more]

Sector Healthcare
Founded 1994
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol CDX
Full Company Profile

Financial Performance

In 2024, CardieX's revenue was 12.81 million, an increase of 125.14% compared to the previous year's 5.69 million. Losses were -6.77 million, -64.18% less than in 2023.

Financial Statements

News

There is no news available yet.